Natco Pharma Ltd
Dibyasmith Parida is a skilled professional currently serving as a Product Manager in the Crop Health Sciences Division at NATCO Pharma since February 2023. Prior experience includes a role as Growth Manager at DeHaat from June 2022 to January 2023 and as Area Marketing Manager at FMC Corporation from April 2021 to April 2022, focusing on marketing management. Previous positions at Chambal Fertilisers and Chemicals Limited involved responsibilities as an Assistant Manager in Marketing, and experience as a summer intern and live project participant at Bayer Crop Science. Early career internships included work at Paradeep Phosphates Limited, contributing to agriculture productivity assessments. Dibyasmith holds a PGDABM in Agribusiness Management from the National Institute of Agricultural Marketing and a B.Sc. in Agriculture from Centurion University of Technology and Management.
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.